BAVIS_1170x120_1-20

Dr. Eric Bastings

FDA approves new preventive treatment for migraines

FDA approves new preventive treatment for migraines

WASHINGTON — The U.S. Food and Drug Administration (FDA) has approved Aimovig (erenumab-aooe) for the preventive treatment of migraine in adults. The treatment is given by once-monthly self-injections. Aimovig is the first FDA-approved preventive migraine treatment in a new class of drugs that work by blocking the activity of calcitonin gene-related peptide, a molecule that